Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : Otlk crawled time : 12:15 save search
Outlook Therapeutics to Present at the Eyecelerator@AAO 2021 Conference Retina Showcases
Published: 2021-11-03 (Crawled : 12:15) - globenewswire.com
OTLK | News P | $8.2 1.36% 1.34% 150K
|
Health Technology
|
| O: 1.44%
H: 2.13%
C: 0.95%
eye retina conference
Outlook Therapeutics to Present at the 2021 American Society of Retina Specialists (ASRS) Annual Meeting
Published: 2021-10-07 (Crawled : 12:15) - globenewswire.com
OTLK | News P | $8.2 1.36% 1.34% 150K
|
Health Technology
|
| O: 2.39%
H: 7.01%
C: 4.21%
retina
Outlook Therapeutics to Present at the Ophthalmology Innovation Summit (OIS) Retina Innovation Showcase
Published: 2021-10-05 (Crawled : 12:15) - globenewswire.com
OTLK | News P | $8.2 1.36% 1.34% 150K
|
Health Technology
|
| O: 0.95%
H: 1.41%
C: -0.47%
retina
Outlook Therapeutics Reports New Positive 12-Month Safety Data from Pivotal Phase 3 NORSE TWO Trial
Published: 2021-09-28 (Crawled : 12:15) - globenewswire.com
OTLK | News P | $8.2 1.36% 1.34% 150K
|
Health Technology
|
| O: -0.44%
H: 0.0%
C: -3.08%
positive phase 3 trial
Outlook Therapeutics Presents Positive NORSE THREE Safety Data for ONS-5010 / LYTENAVA™ (bevacizumab-vikg) at EURETINA Virtual 2021 Medical Conference
Published: 2021-09-13 (Crawled : 12:15) - globenewswire.com
OTLK | News P | $8.2 1.36% 1.34% 150K
|
Health Technology
|
| O: 1.61%
H: 2.57%
C: -0.4%
positive retina conference
Outlook Therapeutics to Present at H.C. Wainwright 23rd Annual Global Investment Conference
Published: 2021-09-08 (Crawled : 12:15) - globenewswire.com
OTLK | News P | $8.2 1.36% 1.34% 150K
|
Health Technology
|
| O: 2.04%
H: 0.0%
C: -4.71%
conference
Outlook Therapeutics Reports Financial Results for Third Quarter of Fiscal Year 2021 and Provides Corporate Update
Published: 2021-08-13 (Crawled : 12:15) - globenewswire.com
OTLK | News P | $8.2 1.36% 1.34% 150K
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
financial results results
Outlook Therapeutics to Participate at the H.C. Wainwright Ophthalmology Virtual Conference
Published: 2021-08-11 (Crawled : 12:15) - globenewswire.com
OTLK | News P | $8.2 1.36% 1.34% 150K
|
Health Technology
|
| O: 0.19%
H: 1.94%
C: 1.74%
conference
Outlook Therapeutics Announces Inclusion in the Russell 2000® Index
Published: 2021-06-14 (Crawled : 12:15) - globenewswire.com
OTLK | News P | $8.2 1.36% 1.34% 150K
|
Health Technology
|
| O: 3.27%
H: 0.11%
C: -3.54%
therapeutics
Outlook Therapeutics Reports Completion of Patient Dosing in the ONS-5010 Pivotal Phase 3 NORSE TWO Trial
Published: 2021-06-08 (Crawled : 12:15) - globenewswire.com
OTLK | News P | $8.2 1.36% 1.34% 150K
|
Health Technology
|
| O: 2.29%
H: 0.12%
C: -1.12%
phase 3 trial
Virtual Clinical Day Recap: Outlook Therapeutics Joined by Drs. Mark Humayun and Firas Rahhal to Discuss Need for FDA-Approved Ophthalmic Bevacizumab and Status of ONS-5010
Published: 2021-05-27 (Crawled : 12:15) - globenewswire.com
OTLK | News P | $8.2 1.36% 1.34% 150K
|
Health Technology
|
| O: 0.0%
H: 5.47%
C: 3.91%
fda fda approval
Outlook Therapeutics Reports Financial Results for Second Quarter of Fiscal Year 2021 and Provides Corporate Update
Published: 2021-05-14 (Crawled : 12:15) - globenewswire.com
OTLK | News P | $8.2 1.36% 1.34% 150K
|
Health Technology
|
| O: 1.03%
H: 7.65%
C: 6.63%
financial results results
Outlook Therapeutics to Host Virtual Clinical Day on May 20, 2021
Published: 2021-05-12 (Crawled : 12:15) - globenewswire.com
OTLK | News P | $8.2 1.36% 1.34% 150K
|
Health Technology
|
| O: -1.96%
H: 4.33%
C: -1.0%
Outlook Therapeutics Reports Positive Safety Profile from NORSE THREE Open-Label Safety Study for ONS-5010 / LYTENAVA™ (bevacizumab-vikg)
Published: 2021-03-31 (Crawled : 12:15) - globenewswire.com
OTLK | News P | $8.2 1.36% 1.34% 150K
|
Health Technology
|
| O: -0.46%
H: 5.07%
C: 3.69%
positive
Gainers vs Losers
| 77% | 23% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 26M
|
AGBA | $2.97 137.6% 57.48% 66M
|
Finance
EDBL | News | $6.59 75.27% 41.8% 2M
|
MTC | $2.24 43.59% 30.67% 6M
|
Technology Services
OPRT | News | $3.15 40.0% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.33 30.39% 24.16% 390K
|
Technology Services
ABVC | $1.35 29.81% 23.53% 7.1M
|
Wholesale Trade
OST | $0.5 25.0% 21.88% 280K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.